RecruitingNCT06279104

A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

Studying Clear cell adenocarcinoma of the ovary

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tongji Hospital
Intervention
physician's choice of chemotherapy(drug)
Enrollment
150 enrolled
Eligibility
18-75 years · FEMALE
Timeline
2023 – 2025

Study locations (1)

Collaborators

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Henan Cancer Hospital · Qilu Hospital of Shandong University · Hubei Cancer Hospital · Anhui Provincial Cancer Hospital · Peking University Cancer Hospital & Institute · Hunan Province Tumor Hospital · First Affiliated Hospital of Suzhou Medical College · Shandong Tumor Hospital · Chongqing University Cancer Hospital · First Affiliated Hospital of Zhongshan Medical University · Peking University Shenzhen Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06279104 on ClinicalTrials.gov

Other trials for Clear cell adenocarcinoma of the ovary

Additional recruiting or active studies for the same condition.

See all trials for Clear cell adenocarcinoma of the ovary →

← Back to all trials